The list of health conditions that benefit from the GLP-1 weight loss and diabetes drugs like Ozempic, Wegovy, Mounjaro and Zepbound, continues to grow. The drugs are already approved to lower the ...
New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.
To learn more about our editorial approach, explore The Direct Message methodology. A class of drugs that millions of people take to manage diabetes and lose weight appears to cut substance use deaths ...
For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their ...
A popular class of weight-loss drugs may prevent life-threatening cardiac complications by opening microscopic blood vessels that often remain blocked after a heart attack, according to a study ...
GLP-1 weight loss drugs have quickly moved from medical journals to household conversations, reshaping how Americans think about obesity, diabetes and weight loss. Headlines often describe them as ...
Preclinical studies in animals have already shown that GLP-1 drugs can reduce reward-seeking behavior. Early clinical work in humans has begun to hint at similar effects. A randomized trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results